News
AWH
0.7700
+0.65%
0.0050
Aspira Women’s Health CEO Transition and Leadership Change
TipRanks · 4d ago
ASPIRA WOMEN'S HEALTH INC - APPOINTS SANDRA MILLIGAN AS INTERIM CEO
Reuters · 4d ago
Aspira Women’s Health Inc. CEO Nicole Sandford Departs; Dr. Sandra Milligan Appointed Interim CEO
Barchart · 4d ago
Aspira CEO Nicole Sandford to depart, Sandra Milligan named interim
TipRanks · 4d ago
Aspira Women’s Health appoints Sandra Milligan as interim CEO as Sandford departs
Seeking Alpha · 4d ago
Press Release: Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO
Dow Jones · 4d ago
Weekly Report: what happened at AWH last week (1209-1213)?
Weekly Report · 4d ago
Aspira Women’s Health Announces Appointment of Dr. Sandra Milligan as Interim CEO
Barchart · 5d ago
Weekly Report: what happened at AWH last week (1202-1206)?
Weekly Report · 12/09 12:20
Aspira Women's Health Inc. Achieves First Milestone in ARPA-H Funding for Endometriosis Diagnostic Development
Barchart · 12/03 17:20
Aspira Women's Health Reaches The First Milestone Of The ARPA-H $10M Award; Aspira Has Received A $2M Cash Payment Under The Terms Of The Related Agreement
Benzinga · 12/03 13:16
Aspira Women’s completes first development milestone of ARPA-H award
TipRanks · 12/03 13:16
Weekly Report: what happened at AWH last week (1125-1129)?
Weekly Report · 12/02 12:21
Weekly Report: what happened at AWH last week (1118-1122)?
Weekly Report · 11/25 12:08
Aspira (AWH) Reports Q3 Loss, Lags Revenue Estimates
NASDAQ · 11/19 22:45
Based on the provided financial report articles, I generated the title for the article: **"Third Quarter 2024 Financial Report: Awakn Holdings plc"** Please note that the title may not be exact, as the provided text does not contain a clear title. However, based on the content and the format of the financial report, I inferred the title to be related to the third quarter financial report of Awakn Holdings plc.
Press release · 11/19 22:34
Aspira: Q3 Earnings Snapshot
Barchart · 11/19 15:43
Weekly Report: what happened at AWH last week (1111-1115)?
Weekly Report · 11/18 12:05
Aspira Women’s Health Reports Q3 2024 Growth and Strategic Advances
TipRanks · 11/15 04:04
Aspira Women’s Health reports Q3 results
Seeking Alpha · 11/14 14:15
More
Webull provides a variety of real-time AWH stock news. You can receive the latest news about Aspira Womens Health Inc through multiple platforms. This information may help you make smarter investment decisions.
About AWH
Aspira Women's Health Inc. is engaged in the discovery, development, and commercialization of noninvasive, artificial intelligence (AI)-powered tests to aid in the diagnosis of gynecologic diseases. The Company's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their initial clinical assessment indicates the mass is indeterminate or benign. The Ova1Plus workflow is designed to assess the risk of ovarian malignancy in women planning for surgery and uses two tests, Ova1 as the primary test and Overa as a reflex for Ova1 intermediate range results. Its in-development test pipeline includes OvaMDxSM risk assessment, EndoCheck and EndoMDx, which are designed to expand its ovarian cancer portfolio and address the tremendous need for noninvasive diagnostics for endometriosis. EndoCheck is a noninvasive test designed to identify endometriomas.